-
Je něco špatně v tomto záznamu ?
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
C. Riggioni, P. Comberiati, M. Giovannini, I. Agache, M. Akdis, M. Alves-Correia, JM. Antó, A. Arcolaci, AK. Azkur, D. Azkur, B. Beken, C. Boccabella, J. Bousquet, H. Breiteneder, D. Carvalho, L. De Las Vecillas, Z. Diamant, I. Eguiluz-Gracia, T....
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
GNT1117687
NHMRC Senior Research Fellowship - International
IJCI-2016-27619
Consejo Superior de Investigaciones Científicas - International
JR19/0029
Instituto de Salud Carlos III - International
PubMed
32535955
DOI
10.1111/all.14449
Knihovny.cz E-zdroje
- MeSH
- alergie komplikace imunologie terapie MeSH
- Betacoronavirus imunologie MeSH
- COVID-19 MeSH
- koronavirové infekce komplikace diagnóza terapie MeSH
- lidé MeSH
- pandemie MeSH
- SARS-CoV-2 MeSH
- virová pneumonie komplikace diagnóza terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in ~9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.
Allergy Unit Department of Pediatrics Meyer Children's University Hospital Florence Italy
Allergy Unit Hospital Universitario 12 de Octubre Madrid Spain
Allergy Unit IBIMA Regional University Hospital of Malaga UMA RETICS ARADyAL BIONAND Malaga Spain
Center for Rhinology and Allergology Wiesbaden Germany
Centre for Inflammation Research Child Life and Health The University of Edinburgh Edinburgh UK
Department of Allergology Zhongnan Hospital of Wuhan University Wuhan China
Department of Allergy Marqués de Valdecilla University Hospital IDIVAL Santander Spain
Department of Medicine Jagiellonian University Medical College Krakow Poland
Department of Otorhinolaryngology Amsterdam University Medical Centers Amsterdam The Netherlands
Department of Virology Faculty of Veterinary Medicine University of Kirikkale Kirikkale Turkey
ENT Department General Hospital of Chania Greece Greece
Faculty of Medicine Transylvania University Brasov Romania
Immuno Allergology Unit Hospital Centre of Luxembourg Luxembourg Luxembourg
ISGlobal Barcelona Institute for Global Health Barcelona Spain IMIM Barcelona Spain
National Heart and Lung Institute Imperial College London London UK
Public Health Research Center NOVA University of Lisbon Lisboa Portugal
Swiss Institute of Allergy and Asthma Research Davos Switzerland
Swiss Institute of Allergy and Asthma Research University of Zurich Davos Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20027748
- 003
- CZ-PrNML
- 005
- 20210114152318.0
- 007
- ta
- 008
- 210105s2020 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/all.14449 $2 doi
- 035 __
- $a (PubMed)32535955
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Riggioni, Carmen $u Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain. Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
- 245 12
- $a A compendium answering 150 questions on COVID-19 and SARS-CoV-2 / $c C. Riggioni, P. Comberiati, M. Giovannini, I. Agache, M. Akdis, M. Alves-Correia, JM. Antó, A. Arcolaci, AK. Azkur, D. Azkur, B. Beken, C. Boccabella, J. Bousquet, H. Breiteneder, D. Carvalho, L. De Las Vecillas, Z. Diamant, I. Eguiluz-Gracia, T. Eiwegger, S. Eyerich, W. Fokkens, YD. Gao, F. Hannachi, SL. Johnston, M. Jutel, A. Karavelia, L. Klimek, B. Moya, KC. Nadeau, R. O'Hehir, L. O'Mahony, O. Pfaar, M. Sanak, J. Schwarze, M. Sokolowska, MJ. Torres, W. van de Veen, MC. van Zelm, Y. Wang, L. Zhang, R. Jiménez-Saiz, CA. Akdis,
- 520 9_
- $a In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in ~9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.
- 650 _2
- $a Betacoronavirus $x imunologie $7 D000073640
- 650 _2
- $a COVID-19 $7 D000086382
- 650 _2
- $a koronavirové infekce $x komplikace $x diagnóza $x terapie $7 D018352
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a alergie $x komplikace $x imunologie $x terapie $7 D006967
- 650 _2
- $a pandemie $7 D058873
- 650 _2
- $a virová pneumonie $x komplikace $x diagnóza $x terapie $7 D011024
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Comberiati, Pasquale $u Section of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Department of Clinical Immunology and Allergology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
- 700 1_
- $a Giovannini, Mattia $u Allergy Unit, Department of Pediatrics, Meyer Children's University Hospital, Florence, Italy.
- 700 1_
- $a Agache, Ioana $u Faculty of Medicine, Transylvania University, Brasov, Romania.
- 700 1_
- $a Akdis, Mübeccel $u Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
- 700 1_
- $a Alves-Correia, Magna $u Allergy Unit, CUF Porto Hospital & Institute, Oporto, Portugal. Faculty of Medicine, Center for Health Technology and Services Research (CINTESIS), University of Porto, Oporto, Portugal.
- 700 1_
- $a Antó, Josep M $u ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. Universitat Pompeu Fabra (UPF), Barcelona, Spain. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
- 700 1_
- $a Arcolaci, Alessandra $u Allergy Unit & Asthma Center, Borgo Roma Hospital, University of Verona and General Hospital, Verona, Italy.
- 700 1_
- $a Azkur, Ahmet Kursat $u Department of Virology, Faculty of Veterinary Medicine, University of Kirikkale, Kirikkale, Turkey.
- 700 1_
- $a Azkur, Dilek $u Division of Pediatric Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, University of Kirikkale, Kirikkale, Turkey.
- 700 1_
- $a Beken, Burcin $u Department of Pediatric Allergy and Immunology, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey.
- 700 1_
- $a Boccabella, Cristina $u Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario "A Gemelli" - IRCCS, University of the Sacred Heart, Rome, Italy.
- 700 1_
- $a Bousquet, Jean $u Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany. Department of Dermatology and Allergy, Comprehensive Allergy Center, Berlin Institute of Health, Berlin, Germany. MACVIA-France, Montpellier, France.
- 700 1_
- $a Breiteneder, Heimo $u Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Carvalho, Daniela $u Public Health Research Center, NOVA University of Lisbon, Lisboa, Portugal.
- 700 1_
- $a De Las Vecillas, Leticia $u Department of Allergy, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain.
- 700 1_
- $a Diamant, Zuzana $u Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden. Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
- 700 1_
- $a Eguiluz-Gracia, Ibon $u Allergy Unit, IBIMA-Regional University Hospital of Malaga, UMA, RETICS ARADyAL, BIONAND, Malaga, Spain.
- 700 1_
- $a Eiwegger, Thomas $u Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, The Hospital for Sick Children, Toronto, ON, Canada. Translational Medicine Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada. Department of Immunology, University of Toronto, Toronto, ON, Canada.
- 700 1_
- $a Eyerich, Stefanie $u ZAUM - Center of Allergy and Environment, Technical University and Helmholtz Center Munich, Munich, Germany.
- 700 1_
- $a Fokkens, Wytske $u Department of Otorhinolaryngology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- 700 1_
- $a Gao, Ya-Dong $u Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- 700 1_
- $a Hannachi, Farah $u Immuno-Allergology Unit, Hospital Centre of Luxembourg, Luxembourg, Luxembourg.
- 700 1_
- $a Johnston, Sebastian L $u National Heart and Lung Institute, Imperial College London, London, UK.
- 700 1_
- $a Jutel, Marek $u Department of Clinical Immunology, University of Wroclaw, Wroclaw, Poland. ALL-MED" Medical Research Institute, Wroclaw, Poland.
- 700 1_
- $a Karavelia, Aspasia $u ENT Department, General Hospital of Chania, Greece, Greece.
- 700 1_
- $a Klimek, Ludger $u Center for Rhinology and Allergology, Wiesbaden, Germany.
- 700 1_
- $a Moya, Beatriz $u Allergy Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
- 700 1_
- $a Nadeau, Kari C $u Division of Pulmonary and Critical Care Medicine, Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, CA, USA.
- 700 1_
- $a O'Hehir, Robyn $u Department of Immunology and Pathology, Monash University, Melbourne, Vic., Australia. Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University and The Alfred Hospital, Melbourne, Vic., Australia.
- 700 1_
- $a O'Mahony, Liam $u Department of Medicine and School of Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.
- 700 1_
- $a Pfaar, Oliver $u Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
- 700 1_
- $a Sanak, Marek $u Department of Medicine, Jagiellonian University Medical College, Krakow, Poland.
- 700 1_
- $a Schwarze, Jürgen $u Centre for Inflammation Research, Child Life and Health, The University of Edinburgh, Edinburgh, UK.
- 700 1_
- $a Sokolowska, Milena $u Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
- 700 1_
- $a Torres, María J $u Allergy Unit, IBIMA-Regional University Hospital of Malaga, UMA, RETICS ARADyAL, BIONAND, Malaga, Spain.
- 700 1_
- $a van de Veen, Willem $u Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
- 700 1_
- $a van Zelm, Menno C $u Department of Immunology and Pathology, Monash University, Melbourne, Vic., Australia. Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University and The Alfred Hospital, Melbourne, Vic., Australia.
- 700 1_
- $a Wang, De Yun $u Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- 700 1_
- $a Zhang, Luo $u Department of Otolaryngology Head and Neck Surgery and Department of Allergy, Beijing Tongren Hospital, Beijing, China.
- 700 1_
- $a Jiménez-Saiz, Rodrigo $u Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB)-CSIC, Madrid, Spain. McMaster Immunology Research Centre (MIRC), Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Madrid, Spain.
- 700 1_
- $a Akdis, Cezmi A $u Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
- 773 0_
- $w MED00009088 $t Allergy $x 1398-9995 $g Roč. 75, č. 10 (2020), s. 2503-2541
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32535955 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114152315 $b ABA008
- 999 __
- $a ok $b bmc $g 1608083 $s 1118928
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 75 $c 10 $d 2503-2541 $e 20200720 $i 1398-9995 $m Allergy $n Allergy $x MED00009088
- GRA __
- $a GNT1117687 $p NHMRC Senior Research Fellowship $2 International
- GRA __
- $a IJCI-2016-27619 $p Consejo Superior de Investigaciones Científicas $2 International
- GRA __
- $a JR19/0029 $p Instituto de Salud Carlos III $2 International
- LZP __
- $a Pubmed-20210105
